SPRY

ARS Pharmaceuticals Inc

Jun 05 • 04:00PM ET

8.56

-0.51 -5.62 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: HRMY SUPN ALKS PRGO BHC AMRX INDV LNTH TEVA VTRS

| Held by: XBI VTI IWM VXF IWO IBB SCHA VTWO SMLF VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.00	Insider Own	36.89%	Shs Outstand	99.30M	Perf Week	-5.62%
Market Cap	850.04M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.00%	Shs Float	62.67M	Perf Month	-7.76%
Enterprise Value	745.59M	PEG	-	EPS next Q	-0.48	Inst Own	74.28%	Short Float	41.35%	Perf Quarter	-5.52%
Income	-197.98M	P/S	8.59	EPS this Y	-0.57%	Inst Trans	-1.02%	Short Ratio	15.16	Perf Half Y	-10.37%
Sales	98.99M	P/B	13.86	EPS next Y	45.37%	ROA	-64.39%	Short Interest	25.91M	Perf YTD	-26.52%
Book/sh	0.62	P/C	4.23	EPS next 5Y	-	ROE	-136.40%	52W High	18.90 -54.71%	Perf Year	-36.31%
Cash/sh	2.02	P/FCF	-	EPS past 3/5Y	-26.04% -12.85%	ROIC	-125.44%	52W Low	6.66 28.53%	Perf 3Y	23.34%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	300.09% -	Gross Margin	74.12%	Volatility	6.74% 7.37%	Perf 5Y	-70.31%
Dividend TTM	-	EV/Sales	7.53	EPS Y/Y TTM	-1130.30%	Oper. Margin	-204.49%	ATR (14)	0.59	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.77	Sales Y/Y TTM	1.92%	Profit Margin	-200.00%	RSI (14)	50.60	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.94	EPS Q/Q	-76.39%	SMA20	2.13%	Beta	0.92	Target Price	28.80
Payout	-	Debt/Eq	1.57	Sales Q/Q	184.47%	SMA50	2.94%	Rel Volume	0.75	Prev Close	9.07
Employees	163	LT Debt/Eq	1.57	Earnings	May 15 BMO	SMA200	-10.38%	Avg Volume	1.71M	Price	8.56
IPO	Dec 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-18.22% 2.17%	Trades		Volume	1,286,032	Change	-5.62%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)